Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
30–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Type 2 diabetes.
HbA1c (a measure of the average amount of sugar in blood over the last 2 or 3 months) levels are between 7.0 and 9.0.
Taking 850mg or more per day metformin, but not taking any other diabetes medications.
Must be medically able and willing to discontinue diabetic medications from at least 2 weeks prior to first study dose until the last study assessment.
Diabetic subjects who have not yet started taking diabetes medications or whose diabetes is controlled by diet alone may also be eligible to enroll if their HbA1c is within 7.5 to 9.0.
You may not be if
Using illicit drugs, or have antibodies to hepatitis B, hepatitis C, or HIV.
Have any major health problems other than type 2 diabetes.
Require insulin therapy or oral antidiabetic medication other than metformin.
Subjects who have had a urinary tract infection within 4 weeks of the start of the study or who have kidney disease.
Subjects with either low or high blood pressure.
Men who are unwilling to abstain from intercourse, or use a condom with a pregnant or nursing female, or who are unwilling to use a condom with another form of contraception with a female who could become pregnant.
Clareo Health | GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
